David W. Gryska's most recent trade in Mind Medicine Inc was a trade of 75,187 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mind Medicine Inc | David W. Gryska | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 75,187 | 75,187 | - | - | Stock Option (Right to Buy) | |
| Forte Biosciences Inc | David W. Gryska | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2025 | 31,000 | 31,000 | - | - | Stock Option (right to buy) | |
| Mind Medicine Inc | W. David Gryska | Director | Purchase of securities on an exchange or from another person at price $ 7.17 per share. | 05 Dec 2024 | 2,500 | 19,851 | - | 7.2 | 17,925 | Common Shares |
| Mind Medicine Inc | David W. Gryska | Director | Purchase of securities on an exchange or from another person at price $ 5.98 per share. | 23 Aug 2024 | 3,500 | 17,351 | - | 6.0 | 20,930 | Common Shares |
| Forte Biosciences Inc | David W. Gryska | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2024 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Mind Medicine Inc | David W. Gryska | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 16,506 | 16,506 | - | - | Stock Option (Right to Buy) | |
| Forte Biosciences Inc | David W. Gryska | Director | Grant, award, or other acquisition of securities at price $ 1.01 per share. | 31 Jul 2023 | 148,514 | 148,514 | - | 1.0 | 149,999 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 2,044 | 51,047 (0%) | 0% | 0 | Common Stock | |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.70 per share. | 13 Feb 2023 | 8,750 | 49,003 (0%) | 0% | 36.7 | 321,125 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2023 | 8,750 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Forte Biosciences Inc | David W. Gryska | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2023 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Seagen Inc | David W. Gryska | Director | Sale of securities on an exchange or to another person at price $ 129.10 per share. | 11 Nov 2022 | 7,500 | 40,253 (0%) | 0% | 129.1 | 968,220 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 3,676 | 3,676 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | David W. Gryska | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 1,503 | 47,753 (0%) | 0% | 0 | Common Stock | |
| Seagen Inc | David W. Gryska | Director | Sale of securities on an exchange or to another person at price $ 143.32 per share. | 19 Apr 2022 | 1,794 | 46,250 (0%) | 0% | 143.3 | 257,116 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2022 | 1,794 | 2,206 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.06 per share. | 19 Apr 2022 | 1,794 | 48,044 (0%) | 0% | 20.1 | 35,988 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2022 | 1,516 | 690 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | David W. Gryska | Director | Sale of securities on an exchange or to another person at price $ 144.17 per share. | 19 Apr 2022 | 1,516 | 46,250 (0%) | 0% | 144.2 | 218,562 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.06 per share. | 19 Apr 2022 | 1,516 | 47,766 (0%) | 0% | 20.1 | 30,411 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Apr 2022 | 690 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | David W. Gryska | Director | Sale of securities on an exchange or to another person at price $ 145.08 per share. | 19 Apr 2022 | 690 | 46,250 (0%) | 0% | 145.1 | 100,105 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.06 per share. | 19 Apr 2022 | 690 | 46,940 (0%) | 0% | 20.1 | 13,841 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 2,371 | 4,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | David W. Gryska | Director | Sale of securities on an exchange or to another person at price $ 139.42 per share. | 07 Feb 2022 | 2,371 | 46,250 (0%) | 0% | 139.4 | 330,565 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.06 per share. | 07 Feb 2022 | 2,371 | 48,621 (0%) | 0% | 20.1 | 47,562 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 1,100 | 7,400 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | David W. Gryska | Director | Sale of securities on an exchange or to another person at price $ 137.45 per share. | 07 Feb 2022 | 1,100 | 46,250 (0%) | 0% | 137.5 | 151,195 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.06 per share. | 07 Feb 2022 | 1,100 | 47,350 (0%) | 0% | 20.1 | 22,066 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Sale of securities on an exchange or to another person at price $ 138.66 per share. | 07 Feb 2022 | 1,029 | 46,250 (0%) | 0% | 138.7 | 142,681 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 1,029 | 6,371 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.06 per share. | 07 Feb 2022 | 1,029 | 47,279 (0%) | 0% | 20.1 | 20,642 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2022 | 2,553 | 9,597 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | David W. Gryska | Director | Sale of securities on an exchange or to another person at price $ 122.43 per share. | 28 Jan 2022 | 2,553 | 46,250 (0%) | 0% | 122.4 | 312,564 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.06 per share. | 28 Jan 2022 | 2,553 | 48,803 (0%) | 0% | 20.1 | 51,213 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2022 | 883 | 8,714 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | David W. Gryska | Director | Sale of securities on an exchange or to another person at price $ 123.39 per share. | 28 Jan 2022 | 883 | 46,250 (0%) | 0% | 123.4 | 108,953 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.06 per share. | 28 Jan 2022 | 883 | 47,133 (0%) | 0% | 20.1 | 17,713 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2022 | 850 | 12,150 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.06 per share. | 28 Jan 2022 | 850 | 47,100 (0%) | 0% | 20.1 | 17,051 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Sale of securities on an exchange or to another person at price $ 121.69 per share. | 28 Jan 2022 | 850 | 46,250 (0%) | 0% | 121.7 | 103,437 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Sale of securities on an exchange or to another person at price $ 124.23 per share. | 28 Jan 2022 | 214 | 46,250 (0%) | 0% | 124.2 | 26,585 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.06 per share. | 28 Jan 2022 | 214 | 46,464 (0%) | 0% | 20.1 | 4,293 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2022 | 214 | 8,500 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.06 per share. | 14 Jan 2022 | 4,500 | 50,750 (0%) | 0% | 20.1 | 90,270 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jan 2022 | 4,500 | 13,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | David W. Gryska | Director | Sale of securities on an exchange or to another person at price $ 135.24 per share. | 14 Jan 2022 | 4,500 | 46,250 (0%) | 0% | 135.2 | 608,581 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 3,462 | 3,462 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | David W. Gryska | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 1,402 | 46,250 (0%) | 0% | 0 | Common Stock | |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2020 | 7,871 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | David W. Gryska | Director | Sale of securities on an exchange or to another person at price $ 173.25 per share. | 19 Nov 2020 | 7,871 | 44,848 (0%) | 0% | 173.3 | 1,363,651 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.02 per share. | 19 Nov 2020 | 7,871 | 52,719 (0%) | 0% | 19.0 | 149,706 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Nov 2020 | 7,129 | 7,871 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | David W. Gryska | Director | Sale of securities on an exchange or to another person at price $ 174.20 per share. | 19 Nov 2020 | 7,129 | 44,848 (0%) | 0% | 174.2 | 1,241,872 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.02 per share. | 19 Nov 2020 | 7,129 | 51,977 (0%) | 0% | 19.0 | 135,594 | Common Stock |
| Seagen Inc | David W. Gryska | Director | Sale of securities on an exchange or to another person at price $ 180.60 per share. | 05 Nov 2020 | 4,500 | 44,848 (0%) | 0% | 180.6 | 812,699 | Common Stock |